Metformin versus clomiphene citrate for ovulation induction in polycystic ovary syndrome: a systematic review
Abstract
Introduction: Polycystic ovary syndrome is one of the most common causes of anovulatory infertility worldwide and represents a major clinical challenge in reproductive endocrinology. Pharmacological ovulation induction remains the cornerstone of treatment for women with this condition who desire pregnancy, with clomiphene citrate and metformin being among the most frequently prescribed agents. Despite decades of clinical use, uncertainty persists regarding the comparative effectiveness and safety of these drugs, particularly in different phenotypic presentations of the syndrome and in contemporary clinical practice.
Objective: The main objective of this systematic review was to compare the efficacy of metformin versus clomiphene citrate for ovulation induction in women with polycystic ovary syndrome. Secondary objectives were to evaluate differences in ovulation rates, clinical pregnancy rates, live birth rates, adverse effects, and treatment tolerability between the two interventions.
Methods: A systematic search was conducted in PubMed, Scopus, Web of Science, Cochrane Library, LILACS, ClinicalTrials.gov, and the International Clinical Trials Registry Platform. Randomized and non-randomized clinical studies comparing metformin and clomiphene citrate for ovulation induction in women with polycystic ovary syndrome were eligible. Study selection, data extraction, and risk of bias assessment were performed independently by two reviewers, with qualitative synthesis of outcomes.…
How strong is the evidence?
Evidence Hub reads this as a systematic review, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid.
Read the paper
Related studies
- Increased expression of circulating miRNA-93 in women with polycystic ovary syndrome may represent a novel, non-invasive biomarker for diagnosis
- Identification of key genes associated with polycystic ovary syndrome (PCOS) and ovarian cancer using an integrated bioinformatics analysis
- Identification of key pathways and genes in polycystic ovary syndrome via integrated bioinformatics analysis and prediction of small therapeutic molecules
- Regulation of Androgen Receptor Expression Alters AMPK Phosphorylation in the Endometrium: In Vivo and In Vitro Studies in Women with Polycystic Ovary Syndrome
- Effect of oral administration of low-dose follicle stimulating hormone on hyperandrogenized mice as a model of polycystic ovary syndrome
- Systems pharmacology to investigate the interaction of berberine and other drugs in treating polycystic ovary syndrome
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.